Gilead Gets Buy, Amgen Holds: Biopharma Calls Roil Markets
Wall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
Index levels matter because they summarize broader market dynamics. This snippet covers why they matter and how traders can incorporate them.
27,098 articlesWall Street resorts to fresh coverage on three large cap biopharma names as Jefferies flags Gilead and Amgen while JP...
CoinFello debuts OpenClaw Skill, enabling Moltbots to perform on-chain actions through narrowly scoped delegations wh...
Credo Technology delivers a blockbuster Q3, yet Marvell’s AI data-center push steals the spotlight. Investors are ret...
A Trump-themed meme coin surged as promoters advertised a Mar-a-Lago gala, with White House attendance unconfirmed an...
Telos (TLS) 2025 earnings signals matter for investors tracking blockchain efficiency and long-term value. This guide...
Arizona regulators filed a 20-count complaint alleging Kalshi engaged in illegal gambling and election wagering. The ...
As rate landscapes shift in 2026, three dividend-focused ETFs provide a disciplined path to durable retirement income...
Swarmer’s 520% debut gain transformed a modest-revenue drone-software company into a market curiosity. With no analys...
A Santa Monica jury ruled Bill Cosby liable for a 1972 assault, awarding $59.25 million in total damages, including $...
Stocks moved higher after a choppy morning, with broad participation lifting the S&P 500 and SPY. Traders are weighin...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
A political clash at the Milan Cortina Games after Trump described a U.S. Olympian as a 'real Loser' has ignited a de...